Analysts Set Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Price Target at $19.14

Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) have been assigned a consensus rating of “Moderate Buy” from the seven analysts that are currently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $19.14.

Several research analysts have weighed in on the company. Wells Fargo & Company upgraded Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $16.00 to $20.00 in a research note on Tuesday, October 1st. Citigroup upgraded shares of Sabra Health Care REIT from a “neutral” rating to a “buy” rating and upped their target price for the stock from $17.00 to $20.00 in a research report on Friday, September 13th. Truist Financial raised their target price on shares of Sabra Health Care REIT from $16.00 to $18.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Mizuho reiterated a “neutral” rating and issued a $20.00 price target on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. Finally, Scotiabank raised their price objective on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “sector perform” rating in a research report on Friday, October 11th.

Sabra Health Care REIT Stock Down 0.7 %

Shares of SBRA stock opened at $17.37 on Friday. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.16 and a quick ratio of 4.16. Sabra Health Care REIT has a one year low of $12.83 and a one year high of $20.03. The company’s fifty day moving average price is $18.51 and its 200-day moving average price is $17.13. The company has a market capitalization of $4.11 billion, a price-to-earnings ratio of 42.37, a PEG ratio of 2.20 and a beta of 1.24.

Sabra Health Care REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.22). The business had revenue of $178.00 million for the quarter, compared to the consensus estimate of $177.19 million. Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. During the same period in the prior year, the business earned $0.34 earnings per share. Sell-side analysts expect that Sabra Health Care REIT will post 1.39 EPS for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 29th. Investors of record on Friday, November 15th were issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.91%. The ex-dividend date was Friday, November 15th. Sabra Health Care REIT’s payout ratio is 292.68%.

Institutional Trading of Sabra Health Care REIT

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Nisa Investment Advisors LLC grew its stake in shares of Sabra Health Care REIT by 3.0% during the second quarter. Nisa Investment Advisors LLC now owns 127,738 shares of the real estate investment trust’s stock valued at $1,967,000 after buying an additional 3,667 shares during the last quarter. Van Lanschot Kempen Investment Management N.V. grew its position in Sabra Health Care REIT by 461.0% in the 2nd quarter. Van Lanschot Kempen Investment Management N.V. now owns 563,844 shares of the real estate investment trust’s stock valued at $8,683,000 after acquiring an additional 463,344 shares during the last quarter. Family Firm Inc. purchased a new stake in Sabra Health Care REIT in the second quarter worth $26,000. LDR Capital Management LLC lifted its position in shares of Sabra Health Care REIT by 4.7% during the second quarter. LDR Capital Management LLC now owns 454,219 shares of the real estate investment trust’s stock worth $6,995,000 after purchasing an additional 20,554 shares during the last quarter. Finally, Arkadios Wealth Advisors purchased a new stake in shares of Sabra Health Care REIT during the second quarter valued at $305,000. Hedge funds and other institutional investors own 99.40% of the company’s stock.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.